- Home
- GSK vs ELV Comparison
GSK vs ELV Comparison
Compare GSK & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- ELV
- Stock Information
- Founded
- GSK 1715
- ELV 1944
- Country
- GSK United Kingdom
- ELV United States
- Employees
- GSK N/A
- ELV N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- ELV Medical Specialities
- Sector
- GSK Health Care
- ELV Health Care
- Exchange
- GSK Nasdaq
- ELV Nasdaq
- Market Cap
- GSK 77.1B
- ELV 61.8B
- IPO Year
- GSK N/A
- ELV N/A
- Fundamental
- Price
- GSK $39.32
- ELV $309.43
- Analyst Decision
- GSK Hold
- ELV Buy
- Analyst Count
- GSK 2
- ELV 15
- Target Price
- GSK N/A
- ELV $411.86
- AVG Volume (30 Days)
- GSK 4.6M
- ELV 2.8M
- Earning Date
- GSK 07-30-2025
- ELV 07-17-2025
- Dividend Yield
- GSK 4.11%
- ELV 2.21%
- EPS Growth
- GSK N/A
- ELV N/A
- EPS
- GSK 1.13
- ELV 23.39
- Revenue
- GSK $43,336,073,439.00
- ELV $189,254,000,000.00
- Revenue This Year
- GSK $5.56
- ELV $12.33
- Revenue Next Year
- GSK $5.08
- ELV $5.76
- P/E Ratio
- GSK $16.52
- ELV $13.24
- Revenue Growth
- GSK 0.59
- ELV 10.21
- 52 Week Low
- GSK $31.72
- ELV $273.71
- 52 Week High
- GSK $44.67
- ELV $567.26
- Technical
- Relative Strength Index (RSI)
- GSK 59.10
- ELV 53.53
- Support Level
- GSK $36.75
- ELV $290.47
- Resistance Level
- GSK $39.33
- ELV $298.91
- Average True Range (ATR)
- GSK 0.66
- ELV 8.68
- MACD
- GSK 0.26
- ELV 5.75
- Stochastic Oscillator
- GSK 99.61
- ELV 93.29
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About ELV Elevance Health Inc.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.